Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction (Q34321881)

1 August 2017

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction (English)

1 reference

1 August 2017

1 reference

M J Brisco

1

1 reference

1 August 2017

J Condon

2

1 reference

1 August 2017

E Hughes

3

1 reference

1 August 2017

S H Neoh

4

1 reference

1 August 2017

P J Sykes

5

1 reference

1 August 2017

R Seshadri

6

1 reference

1 August 2017

I Toogood

7

1 reference

1 August 2017

K Waters

8

1 reference

1 August 2017

G Tauro

9

1 reference

1 August 2017

H Ekert

10

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 January 1994

1 reference

1 August 2017

1 reference

1 August 2017

343

1 reference

1 August 2017

8891

1 reference

1 August 2017

196-200

1 reference

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990988-1

7 January 2021

Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990988-1

7 January 2021

Rapid, nonradioactive detection of clonal T-cell receptor gene rearrangements in lymphoid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990988-1

7 January 2021

Immunoglobulin gene 'fingerprinting': an approach to analysis of B lymphoid clonality in lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990988-1

7 January 2021

Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990988-1

7 January 2021

Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990988-1

7 January 2021

Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990988-1

7 January 2021

Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990988-1

7 January 2021

Detection and quantitation of neoplastic cells in acute lymphoblastic leukaemia, by use of the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990988-1

7 January 2021

Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990988-1

7 January 2021

Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990988-1

7 January 2021

The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990988-1

7 January 2021

Detection of minimal residual disease in childhood leukemia with the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990988-1

7 January 2021

10.1016/S0140-6736(94)90988-1

Identifiers

DOI

1 reference

1 August 2017

1 reference